MedMira Inc - Asset Resilience Ratio

Latest as of October 2002: 3.09%

MedMira Inc (MIR) has an Asset Resilience Ratio of 3.09% as of October 2002. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See MIR FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.

Liquid Assets

CA$73.82K

≈ $53.40K USD Cash + Short-term Investments

Total Assets

CA$2.39 Million

≈ $1.73 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2001–2002)

This chart shows how MedMira Inc's Asset Resilience Ratio has changed over time. See MedMira Inc net asset quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down MedMira Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of MedMira Inc.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CA$0.00	0%
Short-term Investments	CA$73.82K	3.09%
Total Liquid Assets	CA$73.82K	3.09%

Asset Resilience Insights

Limited Liquidity: MedMira Inc maintains only 3.09% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

MedMira Inc Industry Peers by Asset Resilience Ratio

Compare MedMira Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Spyre Therapeutics Inc. NASDAQ:SYRE	Biotechnology	84.34%
3SBio Inc F:83B	Biotechnology	10.64%
Soleno Therapeutics Inc NASDAQ:SLNO	Biotechnology	20.15%
Jiangxi Fushine Pharmaceutical Co Ltd SHE:300497	Biotechnology	0.02%
Novavax Inc NASDAQ:NVAX	Biotechnology	53.87%
BB Biotech AG SW:BION	Biotechnology	0.05%

Annual Asset Resilience Ratio for MedMira Inc (2001–2002)

The table below shows the annual Asset Resilience Ratio data for MedMira Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2002-07-31	2.20%	CA$73.82K ≈ $53.40K	CA$3.36 Million ≈ $2.43 Million	-0.19pp
2001-07-31	2.39%	CA$72.35K ≈ $52.33K	CA$3.03 Million ≈ $2.19 Million	--

pp = percentage points

About MedMira Inc

V:MIR Canada Biotechnology

Market Cap

$33.00 Million

CA$45.61 Million CAD

Market Cap Rank

#23486 Global

#868 in Canada

Share Price

CA$0.07

Change (1 day)

+0.00%

52-Week Range

CA$0.06 - CA$0.10

All Time High

CA$0.70